Markets

DaVita Inc

stock
DVA· NYSE· Health Care

181.78

+2.53 (+1.41%)

Price as of 13 Oct, 19:56 · Rate limit reached. Please try again in a minute.

1 Sept8 Sept14 Sept18 Sept24 Sept30 Sept6 Oct12 Oct174180186192198
Open—
Mkt cap15.21bn USD
Dividend—
High—
P/E ratio22.83
PEG ratio0.74
Low—
52-wk high—
52-wk low—
40

Good Money Guide Pro Score

Neutral

Mixed investment profile

Technical Analysis

Short-Term Outlook

Bullish

2 bull · 1 bear · 2 neutral

Medium-Term Outlook

Bullish

4 bull · 0 bear · 0 neutral

Moving Average (50d)
Bullish
181.29

Price above 50-day MA

Moving Average (200d)
Bullish
172.29

Price above 200-day MA

EMA (12d)
Bullish
179.59

Price above 12-day EMA

EMA (26d)
Bullish
181.07

Price above 26-day EMA

RSI (14)
Neutral
51.4

Neutral momentum zone

MACD
Bullish
-1.48

MACD above signal line

Stochastic Oscillator
Bearish
82.7%

Overbought — potential reversal down

Bollinger Bands
Neutral
180.12

Price near middle band

Standard Deviation
Neutral
4.32

Volatility measure — informational only

Volume Indicators

On Balance Volume (OBV)

21 May23 Jun23 Jul21 Aug22 Sept-8000000-400000008.0M

Volume Accumulation Distribution (VAD)

21 May23 Jun23 Jul21 Aug22 Sept-6000000-300000006.0M

Market Statistics

Day Change

+2.53

Market Cap

15209919000

Exchange

NYSE

Sector

Health Care

Fundamentals

Rate limit reached. Please try again in a minute.

Analyst Forecast

Rate limit reached. Please try again in a minute.

Fundamental Analysis

Unable to load fundamental data

Learn about DaVita Inc

What is DaVita Inc?

DaVita Inc. is a leading healthcare provider in the United States, primarily known for its extensive network of dialysis centers that treat patients suffering from chronic kidney failure. The company also operates a specialized medical group and provides integrated care management services to improve outcomes for individuals with complex health needs. Through its vast clinical footprint, DaVita plays a critical role in supporting patients with end-stage renal disease.

Is DaVita Inc a good investment?

DaVita benefits from a strong market position and consistent demand for life-sustaining kidney care, though it faces risks related to government reimbursement rates and labor costs. While its operational scale can provide stability, potential investors should consider regulatory pressures and the cyclical nature of healthcare markets. Please remember that this information is for educational purposes and does not constitute personalized financial advice.

How do you invest in DaVita Inc?

You can invest in DaVita by purchasing its shares directly through a licensed brokerage platform using the ticker symbol DVA. Additionally, you may gain exposure to the company through broad healthcare sector ETFs or managed mutual funds that include DaVita as a constituent holding. Always ensure you have a brokerage account set up and research your individual financial goals before placing an order.

Educational content generated by AI — not financial advice.

Time & Sales

No trades yet.

News & Sentiment

Rate limit reached. Please try again in a minute.

Share your opinion

Log in or sign up to share your opinion.

Sign up

Community Discussion

No posts yet for DVA — be the first to start the discussion.

Trade

Log in or sign up to place simulated trades.

Sign up

Point & Figure Analysis

OHLC

O: 182.58
H: 183.70
L: 181.69
C: 182.08
V: 400,895

Signals

as of 13 Oct 2026
TrendBull
RelativeBull ▲
Strength
Last Climax (BUY)(07 May 2026)
Last Climax (SELL)(07 Aug 2026)
Last KDR (BOUNCE)(13 Oct 2026)
Last POS (REVERSAL)(07 Oct 2026)
Last MA Crossover(GOLDEN) 13 Mar 2026

Targets

Bull to:186.00 ▲
Stop loss at:176.00

© 2026 Good Money Guide Pro. All rights reserved.

All content copyright Good Money Guide Pro. Good Money Guide Pro is a registered trademark and is owned and operated by RJBCO Ltd. Registered in England & Wales, Company Number: 07134687. Registered office at 11 Old Bond Street, Mayfair, London W1S 4PN. VAT registration number: 324242143. Data protection registration number: ZA468875.

The information contained in this website is for informational purposes only and does not constitute financial advice. The material does not contain (and should not be construed as containing) investment advice or an investment recommendation, or, an offer of or solicitation for, a transaction in any financial instrument.